Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control (managing psych)
Your research study is about evaluating the effectiveness of **Mindfulness-Based Cognitive Therapy (MBCT)** in reducing psychological distress among psoriasis patients and improving their self-compassion and Mental Health Locus of Control (MHLC).
The study highlights that psoriasis patients often suffer not only from physical symptoms but also from psychological problems such as stress, anxiety, depression, self-judgment, and low self-compassion. Traditional treatments mainly focus on physical symptoms and may not fully address these emotional and psychological difficulties.
To address this gap, the study proposes MBCT as a psychological intervention that combines mindfulness practices with cognitive therapy techniques. MBCT helps patients become more self-aware, reduce negative thinking, and develop self-compassion without self-judgment. The research also explores MHLC, which refers to how much control individuals believe they have over their health outcomes.
The study aims to investigate whether MBCT can:
- Reduce psychological distress, anxiety, depression, and stress levels
- Improve self-compassion among psoriasis patients
- Shift patients' locus of control from external to internal
- Enhance emotional well-being and coping mechanisms
The research follows a quantitative experimental design conducted in phases. Initially, baseline levels of distress, MHLC, and self-compassion will be assessed. Later, MBCT interventions will be implemented and evaluated for effectiveness.
Overall, the study seeks to contribute to integrated psoriasis care by emphasizing the importance of psychological health alongside physical treatment, ultimately improving patients' quality of life and therapeutic outcomes.
調査の概要
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Rafia Ghaffar, Phd
- 電話番号:923336096376
- メール:rafiaghaffar1@gmail.com
研究場所
-
-
Punjab Province
-
Rahim Yar Khan、Punjab Province、パキスタン、64200
- 募集
- Department of Dermatologist Sheikh Zayed Hospital Rahim Yar Khan
-
コンタクト:
- Arslan Khalid, Assistant Professor IUB
- 電話番号:923006700809
- メール:arslan.khalid@iub.edu.pk
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Diagnosed psoriasis patients
- Age between 18 and 65 years
- Both male and female participants
- Participants willing to provide informed consent
- Participants experiencing psychological distress
Exclusion Criteria:
- Under the age of 18 years will be excluded.
- Patients with severe psychiatric disorders
- Patients currently receiving other psychological therapies
- Patients with serious medical or neurological conditions
- Participants unwilling to continue the intervention sessions
- Patients with cognitive impairment affecting participation
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Experimental Group
Participants in this group will receive Mindfulness-Based Cognitive Therapy (MBCT) intervention.
|
Mindfulness-Based Cognitive Therapy (MBCT) will be administered to psoriasis patients to reduce psychological distress and improve self-compassion and mental health locus of control.
The intervention includes mindfulness practices and cognitive behavioral techniques delivered in structured sessions.
|
|
実験的:Control Group
Participants in this group will receive usual care without MBCT intervention.
|
Participants in the control group will receive usual care without Mindfulness-Based Cognitive Therapy intervention.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Reduction in Psychological Distress
時間枠:12 weeks
|
To evaluate the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in reducing psychological distress among psoriasis patients.
|
12 weeks
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 403/ub/szmc/szh
- ref no 403/ub/szmc/szh (レジストリ識別子:Sheikh Zayed Medical College/Hospital, Rahim Yar Khan)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。